BioSpace News Archive

Business

4D pharma appoints John Doyle as Chief Financial Officer

4D pharma plc today announces the appointment of John Doyle as Chief Financial Officer (CFO).

January 3, 2022
·
3 min read
Lone Star Bio

Taysha Gene Therapies to Participate in Panel Discussions at the LifeSci Partners 11th Annual Corporate Access Event

Taysha Gene Therapies to Participate in Panel Discussions at the LifeSci Partners 11th Annual Corporate Access Event.

January 3, 2022
·
1 min read
Genetown

Alnylam to Webcast Presentation at 40th Annual J.P. Morgan Healthcare Conference

Alnylam to Webcast Presentation at 40th Annual J.P. Morgan Healthcare Conference.

January 3, 2022
·
2 min read
Deals

Xeris Biopharma Enters Into Agreement for $30 Million Private Placement

Xeris Biopharma Holdings, Inc. today announced that on January 2, 2022, it entered into a securities purchase agreement in connection with a private placement (the “Private Placement”) with an affiliate of Armistice Capital, LLC.

January 3, 2022
·
7 min read
Drug Development

Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication

Anebulo Pharmaceuticals, Inc. announces that the first patient has dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

January 3, 2022
·
4 min read
Genetown

Deciphera Pharmaceuticals, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022, at 9:00 AM ET.

January 3, 2022
·
1 min read
Drug Development

Pieris Pharmaceuticals Announces Successful Completion of Safety Milestone and Initiation of Efficacy Portion of Phase 2a Trial of PRS-060/AZD1402

Pieris Pharmaceuticals, Inc. today announced the successful completion of the sponsor safety review of part 1a of the multi-center, placebo-controlled phase 2a study of dry powder inhaler-formulated PRS-060/AZD1402.

January 3, 2022
·
6 min read
Pharm Country

NRx Pharmaceuticals Files Provisional Patent for Stable Compositions of Aviptadil Suitable for Human Use

NRx Pharmaceuticals (Nasdaq: NRXP) announced today that it has filed a provisional composition of matter patent application with the US Patent and Trademark Office entitled “Stable, Buffer-free Compositions of Vasoactive Intestinal Peptide (VIP).”

January 3, 2022
·
6 min read
Genetown

Relay Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 9:45 a.m. ET.

January 3, 2022
·
1 min read
Biotech Beach

Otonomy to Participate in the H.C. Wainwright BioConnect Conference

Otonomy, Inc. today announced its participation in the H.C. Wainwright BioConnect Virtual Conference. A pre-recorded company presentation by the Otonomy management team will be available on the conference website beginning at 7 a.m. ET / 4 a.m. PT on January 10, 2022.

January 3, 2022
·
1 min read